Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

20.40
Delayed Data
As of Apr 20
 -0.05 / -0.24%
Today’s Change
11.85
Today|||52-Week Range
21.01
+46.24%
Year-to-Date

Today’s Trading

Previous close20.45
Today’s open20.35
Day’s range20.20 - 20.58
Volume290,051
Average volume (3 months)849,195
Market cap$1.4B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-287.10%
Earnings growth (this year)-0.13%
Earnings growth (next 5 years)--
Revenue growth (last year)+26.70%
P/E ratioNM
Price/Sales7.35
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...-0.15-0.78%
XLRNAcceleron Pharma Inc-0.32-0.89%
----
EPZMEpizyme Inc-0.20-1.25%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$138.9M
Annual profit (last year)-$88.1M
Net profit margin-63.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts